{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:53:00Z","timestamp":1791118380882,"version":"4.1.0"},"reference-count":44,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,2,5]],"date-time":"2005-02-05T00:00:00Z","timestamp":1107561600000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:p><jats:bold>Aims<\/jats:bold> :\u2002To study the expression of phosphorylated vascular endothelial growth factor receptor 2 (VEGFR2), a membrane\u2010bound tyrosine kinase receptor to vascular endothelial growth factor, in lymphoma and non\u2010neoplastic lymphadenopathy.<\/jats:p><jats:p><jats:bold>Methods and results<\/jats:bold> :\u2002Archival cases (89 cases of lymphoma and 17 cases of non\u2010neoplastic lymphadenopathy) were studied immunohistochemically with three monoclonal antibodies to the different autophosphorylation sites in the cytoplasmic tail of the receptor. There was increased expression of this receptor in lymphoma and particularly in all cases of peripheral T\u2010cell lymphoma. In this category, there was nuclear re\u2010location of this receptor.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> :\u2002This very interesting finding raises the possibility that VEGFR2 may be involved in the transcriptional regulation of this disease. Small molecule inhibitors to this receptor may therefore be a useful adjunct in the therapy of this disease.<\/jats:p>","DOI":"10.1111\/j.1365-2559.2005.02081.x","type":"journal-article","created":{"date-parts":[[2005,2,6]],"date-time":"2005-02-06T02:19:18Z","timestamp":1107656358000},"page":"209-216","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The expression and cellular localization of phosphorylated VEGFR2 in lymphoma and non\u2010neoplastic lymphadenopathy: an immunohistochemical study"],"prefix":"10.1111","volume":"46","author":[{"given":"G","family":"Pillai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Turley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R D","family":"Leek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Blasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Pezzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A L","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K C","family":"Gatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,2,5]]},"reference":[{"key":"e_1_2_15_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01752.x"},{"key":"e_1_2_15_3_2","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V96.6.2240","article-title":"Angiogenesis in acute and chronic myeloid leukaemia and myelodysplastic syndromes","volume":"96","author":"Aguayo AR","year":"1999","journal-title":"Blood"},{"key":"e_1_2_15_4_2","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1182\/blood.V96.9.3181","article-title":"In vitro and in vivo production of vascular endothelial growth factor in chronic lymphocytic leukaemia cells","volume":"96","author":"Chen H","year":"2000","journal-title":"Blood"},{"key":"e_1_2_15_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401825"},{"key":"e_1_2_15_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6693515"},{"key":"e_1_2_15_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402220"},{"key":"e_1_2_15_8_2","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood.V93.9.3064.409k07_3064_3073","article-title":"Bone marrow neovascularisation, plasma cell angiogenic potential and matrix metalloproteinase 2 secretion parallel progression of human multiple myeloma","volume":"93","author":"Vacca A","year":"1999","journal-title":"Blood"},{"key":"e_1_2_15_9_2","first-page":"800","article-title":"Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood","volume":"85","author":"Di Raimondo FD","year":"2000","journal-title":"Haematologica"},{"key":"e_1_2_15_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-1048.2002.03364.x"},{"key":"e_1_2_15_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(20000115)85:2<171::AID-IJC4>3.0.CO;2-W"},{"key":"e_1_2_15_12_2","first-page":"551","article-title":"Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies","volume":"28","author":"Bellamy WT.","year":"2001","journal-title":"Cancer Res."},{"key":"e_1_2_15_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04133.x"},{"key":"e_1_2_15_14_2","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1182\/blood.V94.10.3334.422k18_3334_3339","article-title":"Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non Hodgkin's lymphoma","volume":"94","author":"Salven P","year":"1999","journal-title":"Blood"},{"key":"e_1_2_15_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01547.x"},{"key":"e_1_2_15_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03253.x"},{"key":"e_1_2_15_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6823562"},{"key":"e_1_2_15_18_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2479986"},{"key":"e_1_2_15_19_2","first-page":"1677","article-title":"Identification of a new endothelial cell growth factor receptor tyrosine kinase","volume":"6","author":"Terman BI","year":"1991","journal-title":"Oncogene"},{"key":"e_1_2_15_20_2","doi-asserted-by":"publisher","DOI":"10.1515\/BC.2002.177"},{"key":"e_1_2_15_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201047"},{"key":"e_1_2_15_22_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.18.11197"},{"key":"e_1_2_15_23_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.47.31283"},{"key":"e_1_2_15_24_2","doi-asserted-by":"publisher","DOI":"10.3109\/08977199409010985"},{"key":"e_1_2_15_25_2","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1523\/JNEUROSCI.16-19-06089.1996","article-title":"Flk\u20101, a receptor for vascular endothelial growth factor (VEGF) is expressed by retinal progenitor cells","volume":"16","author":"Yang K","year":"1996","journal-title":"J. Neuroscience"},{"key":"e_1_2_15_26_2","first-page":"5687","article-title":"Expression of the vascular endothelial growth factor receptor gene, KDR, in haematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionising radiation","volume":"55","author":"Katoh O","year":"1995","journal-title":"Cancer Res."},{"key":"e_1_2_15_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.11.2768"},{"key":"e_1_2_15_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990621)84:3<293::AID-IJC16>3.0.CO;2-T"},{"key":"e_1_2_15_29_2","first-page":"1573","article-title":"Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells","volume":"79","author":"Herold\u2010Mende C","year":"1999","journal-title":"Lab. Invest."},{"key":"e_1_2_15_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2003.01644.x"},{"key":"e_1_2_15_31_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.191117498"},{"key":"e_1_2_15_32_2","first-page":"957","article-title":"Treatment of malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation","volume":"6","author":"Yano S","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_15_33_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1999.5658"},{"key":"e_1_2_15_34_2","first-page":"23","article-title":"The emerging role of angiogenesis inhibitors in hematologic malignancies","volume":"16","author":"Giles FJ.","year":"2002","journal-title":"Oncology"},{"key":"e_1_2_15_35_2","first-page":"397","article-title":"[Receptors for factors of the VEGF (vascular endothelial growth family)]","volume":"84","author":"Fournier E","year":"1997","journal-title":"Bull. Cancer"},{"key":"e_1_2_15_36_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1634"},{"key":"e_1_2_15_37_2","doi-asserted-by":"publisher","DOI":"10.1247\/csf.26.25"},{"key":"e_1_2_15_38_2","first-page":"2594","article-title":"Differential inhibition of fluid accumulation and tumour growth in two mouse ascites tumours by an anti\u2010vascular endothelial growth factor\/permeability factor neutralising antibody","volume":"58","author":"Luo J\u2010C","year":"1998","journal-title":"Cancer Res."},{"key":"e_1_2_15_39_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-1084fje"},{"key":"e_1_2_15_40_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.142224299"},{"key":"e_1_2_15_41_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1065412"},{"key":"e_1_2_15_42_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1067628"},{"key":"e_1_2_15_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1001-e221"},{"key":"e_1_2_15_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncb0901-802"},{"key":"e_1_2_15_45_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0224"}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2559.2005.02081.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2559.2005.02081.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T11:49:49Z","timestamp":1697197789000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2559.2005.02081.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1111\/j.1365-2559.2005.02081.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2559.2005.02081.x","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"2005-02-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}